Valuation: Omnicell, Inc.

Capitalization 1.39B 1.19B 1.11B 1.03B 1.91B 120B 2.12B 13.29B 5.08B 55.87B 5.23B 5.12B 204B P/E ratio 2025 *
-292x
P/E ratio 2026 * 216x
Enterprise value 1.39B 1.19B 1.11B 1.03B 1.91B 120B 2.12B 13.29B 5.08B 55.87B 5.23B 5.12B 204B EV / Sales 2025 *
1.23x
EV / Sales 2026 * 1.19x
Free-Float
80.46%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.57%
1 week-0.23%
Current month+1.26%
1 month-4.71%
3 months-4.21%
6 months-29.59%
Current year-33.13%
More quotes
1 week 28.81
Extreme 28.81
30.55
1 month 27.7
Extreme 27.7
30.57
Current year 22.66
Extreme 22.66
47.69
1 year 22.66
Extreme 22.66
55.74
3 years 22.66
Extreme 22.66
117.56
5 years 22.66
Extreme 22.66
187.28
10 years 22.66
Extreme 22.66
187.28
More quotes
Manager TitleAgeSince
Chief Executive Officer 67 2002-09-30
Director of Finance/CFO 54 2023-05-31
Chief Tech/Sci/R&D Officer - 2025-03-30
Director TitleAgeSince
Chairman 67 1992-08-31
Director/Board Member 69 2012-12-31
Director/Board Member 69 2013-12-31
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.57%-0.23%+16.24%-74.46% 1.39B
-0.96%-0.34%+54.55%+34.08% 46.02B
-0.11%+3.24%+137.39%+595.16% 21.78B
+0.36%+2.52%+50.55%+129.28% 7.21B
-0.10%-3.16% - - 1.56B
-0.53%-4.26%-41.23%-66.45% 1.3B
+0.28%+2.16%+159.88%+452.10% 1.27B
-0.73%-1.97%+69.04%-22.33% 1.18B
-0.62%-8.60%-0.21% - 1.01B
-1.91%-3.62%+17.14%-1.46% 813M
Average -0.50%+0.41%+51.48%+130.74% 8.35B
Weighted average by Cap. -0.58%+2.61%+74.82%+195.38%
See all sector performances

Financials

2025 *2026 *
Net sales 1.13B 968M 902M 834M 1.55B 97.03B 1.72B 10.79B 4.12B 45.34B 4.24B 4.16B 166B 1.17B 1B 936M 865M 1.61B 101B 1.79B 11.19B 4.27B 47.02B 4.4B 4.31B 172B
Net income -4.84M -4.14M -3.86M -3.57M -6.63M -415M -7.38M -46.18M -17.64M -194M -18.17M -17.79M -709M 7.56M 6.47M 6.02M 5.57M 10.34M 648M 11.51M 72.03M 27.51M 303M 28.34M 27.76M 1.11B
Net Debt - -
More financial data * Estimated data
Logo Omnicell, Inc.
Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.
Employees
3,620
More about the company
Date Price Change Volume
25-07-10 29.77 $ -0.57% 303,144
25-07-09 29.94 $ +0.94% 287,497
25-07-08 29.66 $ +2.56% 505,675
25-07-07 28.92 $ -3.08% 415,819
25-07-03 29.84 $ +0.13% 185,031

Delayed Quote Nasdaq, July 10, 2025 at 04:00 pm EDT

More quotes
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
29.77USD
Average target price
43.00USD
Spread / Average Target
+44.44%
Consensus

Quarterly revenue - Rate of surprise